Ocuphire promotes Ronil Patel to Chief Business Officer; grants 74K options and 50K RSUs

Opus Genetics, Inc.

Ronil Patel, age 40, promoted to Chief Business Officer effective December 1, 2023; previously SVP of Operations and Business Development.
Base salary set at $350,000, increasing to $400,000 upon meeting certain milestones (e.g., $100M cash balance or strategic term sheet).
Eligible for annual bonus targeted at 45% of base salary (up from 40%).
Granted incentive stock option to purchase 74,538 shares and RSU for 49,692 shares, vesting over ~2.5 years.
Background: 15 years experience; involved in deals over $300M; previously at Point Guard Partners.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Ronil Patel

Chief Business Officer

IRD · Opus Genetics, Inc.

Effective: 2023-12-01
Filed: December 6, 2023, 6:59 PM ET

On December 1, 2023, the Board of Directors (the "Board" ) of Ocuphire Pharma, Inc. (the "Company" ) promoted Ronil Patel , age 40, as the Company’s Chief Business Officer, effective as of December 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronil Patel changed role as Chief Business Officer at Opus Genetics, Inc..

Action: promoted
Role: Chief Business Officer

Exact text from the filing

On December 1, 2023, the Board of Directors (the "Board" ) of Ocuphire Pharma, Inc. (the "Company" ) promoted Ronil Patel , age 40, as the Company’s Chief Business Officer, effective as of December 1, 2023.

View on SEC.gov

Opus Genetics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-056425

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.